Nektar Therapeutics (CA) Reports Financial Results for the First Quarter of 2013

Published: May 10, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

SAN FRANCISCO, May 9, 2013 /PRNewswire/ -- Nektar Therapeutics (NKTR) today reported its financial results for the first quarter ended March 31, 2013.

Cash and investments in marketable securities at March 31, 2013 were $261.2 million as compared to $302.2 million at December 31, 2012.

Help employers find you! Check out all the jobs and post your resume.

Back to news